Conclusions
It can be concluded that in general factor VIII inhibitor testing showed a large between- laboratory variability. The results of the users of the Nijmegen modified assay are more comparable than those of the users of the classical Bethesda assay. Furthermore, testing of factor VIII inhibitors needs further standardization and improvement of the sensitivity and specificity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Verlag Berlin Heidelberg
About this paper
Cite this paper
Meijer, P., Verbruggen, H., Arnout, J., Spannagl, M. (2007). Global ECAT Survey on Factor VIII Inhibitor Testing: Results of an Inter-Laboratory Pilot Study. In: Scharrer, I., Schramm, W. (eds) 36th Hemophilia Symposium Hamburg 2005. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-36715-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-540-36715-4_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-36714-7
Online ISBN: 978-3-540-36715-4
eBook Packages: MedicineMedicine (R0)